Key stats
About ISGLHLTCA ETF UNITS
Home page
Inception date
Nov 13, 2001
Replication method
Physical
Dividend treatment
Distributes
Income tax type
Capital Gains
Primary advisor
BlackRock Investment Management (Australia) Ltd.
ISIN
AU000000IXJ9
The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
ETF
Bonds, Cash & Other100.00%
ETF99.98%
Cash0.02%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Symbol
Assets
Dividends
Dec '21
Jul '22
Dec '22
Jul '23
Jan '24
Jul '24
Dec '24
0.00
0.30
0.60
0.90
1.20
Dividend amount
Dividend payout history
Ex-date
Record date
Pay date
Amount
Frequency
Dec 27, 2024
Dec 30, 2024
Jan 9, 2025
0.781
Final
Jul 1, 2024
Jul 2, 2024
Jul 11, 2024
0.867
Interim
Jan 2, 2024
Jan 3, 2024
Jan 12, 2024
0.719
Final
Jul 3, 2023
Jul 4, 2023
Jul 13, 2023
1.160
Interim